Monthly Horizon Scanning Report – August 2021

Monthly horizon scanning reports are designed to inform the NHS about new products, significant changes to product licenses, significant new guidance, and decisions that have been made by recognised bodies

This information is produced for use by NHS healthcare professionals. 

Atrial Fibrillation [NICE NG196]: Financial and commissioning impact

In April 2021, NICE published a new guideline NG196 – Atrial fibrillation: diagnosis and management which updates and replaces NICE CG180 (2014). There are a number of new recommendations, which are likely to have both a significant financial impact and potentially affect the way anticoagulation monitoring is managed. This bulletin aims to raise awareness of the commissioning and financial impact of this new guideline.

There are five versions of this publication; please select the appropriate version for your region below.

Wound Management & Other Dressings

Overview

This report looks at prescribing trends in primary care for Wound Management & Other Dressings at CCG and STP level with particular focus on antibiotic dressings.

If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net

Frequency

Annually

Data Period

April 2018 to March 2021

Oral Nutrition

Overview

This report looks at prescribing trends in primary care for Oral Nutrition at CCG and STP level with particular focus on Enteral Nutrition, Foods for Special Diets and Infant Feeds.

If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net

Frequency

Annually

Data Period

April 2018 to March 2021

Gastro-intestinal System

Overview

This report looks at prescribing trends in primary care for for the Gastro-intestinal system at CCG and STP level with particular focus on Dyspepsia, Antisecretory drugs, Acute Diarrhoea, Chronic Bowel Disorders and Laxatives.

If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net

Frequency

Bi-annually

Data Period

April 2018 to March 2021

Drugs affecting bone metabolism

Overview

This report looks at prescribing trends in primary care for Drugs affecting bone metabolism at CCG and STP level with selected substances analysed at presentation level and also explores associations between prescribing and hospital admissions relating to hip fractures.

If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net

Frequency

Bi-annually

Data Period

April 2018 to March 2021

Antidepressant drugs

Overview

This report looks at prescribing trends in primary care for Antidepressant drugs at CCG and STP level with particular focus on first choice antidepressant prescribing and exploration of associations between prescribing and improving access to psychological therapies.

If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net

Frequency

Annually

Data Period

April 2019 to March 2022

Drugs for Genito-urinary disorders

Overview

This report looks at prescribing trends in primary care for Drugs for Genito-urinary disorders at CCG and STP level with particular focus on Drugs for Urinary Retention, Drugs for Urinary Frequency, Enuresis and Incontinence and Drugs for Erectile Dysfunction.

If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net

Frequency

Bi-annually

Data Period

April 2018 to March 2021

Inhaler Carbon Impact Assessment Tool

Overview

The NHS Long Term Plan outlines that 4% of the total NHS carbon footprint savings are expected to be realised through a ‘shift to lower carbon inhalers’ equivalent to a 50% reduction in the inhaler carbon footprint. 1,2 The RDTC has developed an inhaler carbon impact assessment tool in response to these targets. It is intended to be used at a commissioning level to estimate the impact of respiratory pathway choices made following a clinical decision making process.

This is not a clinical switch tool and should only be used as a calculator to estimate the impact of respiratory pathway choices already made following a clinical decision making process.

User Verification

Please note that in order to access the tool users not only require an authorised RDTC website account but additional verification details. To request inclusion as a verified user please contact us at nuth.nyrdtc.rxsupp@nhs.net

References

1. NHSE. NHS Long Term Plan.

2. Centre for Sustainable Healthcare (CSH) Networks. Inhalers and NHS Long Term Plan.

Data Period

July 2020 to June 2021

Frequency

Quarterly

Monthly Horizon Scanning Report – May 2021

Monthly horizon scanning reports are designed to inform the NHS about new products, significant changes to product licenses, significant new guidance, and decisions that have been made by recognised bodies. 

This information is produced for use by NHS healthcare professionals.